Los Angeles, CA, United States of America

Noriyuki Kasahara

This inventor holds 21 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 4 EPO patents, primarily in Gene Therapy. Top assignees: University of California, National Institute of Transplantation Foundation, University of Southern California. Active years: 2002-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Noriyuki Kasahara. Retrieved from https://idiyas.com/inventor/noriyuki-kasahara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 

% Patents Active = 57.1

 

 

Average Co-Inventor Count = 3.5

ph-index = 7

Forward Citations = 167(Granted Patents)


Location History:

  • Oakland, CA (US) (2014 - 2015)
  • Miami, FL (US) (2017 - 2020)
  • Los Angeles, CA (US) (2002 - 2021)
  • Belvedere Tiburon, CA (US) (2023)

Company Filing History:


Years Active: 2002-2023

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Gene Therapy
Chemoselection
Immune Evasion
Gene Delivery
Retroviral Vectors
Lentivirus Vectors
Transplant Viability
HPRT Locus
Hybrid Vectors
Screening Kits
Transplant Recipients
Long-Term Viability
21 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Noriyuki Kasahara

Introduction: Noriyuki Kasahara is a prolific inventor based in Los Angeles, CA, with an impressive track record of 21 patents. His groundbreaking work in the field of stem cell transplantation and immunoglobulin analysis has revolutionized medical practices and paved the way for innovative treatment methods.

Latest Patents: Among his latest patents is a revolutionary "Method for chemoselection" that enables radiation-free hematopoietic stem cell transplantation. By utilizing a purine base analog and HPRT-deficient donor HSCs, this method eliminates the need for myeloablative radiation, reducing toxicity and improving patient outcomes. Additionally, Kasahara has developed "Methods and kits for screening transplant recipients and candidates" to assess immunoglobulin isotypes and subclasses in patients, offering valuable insights for transplant success and autoimmune disease prognosis.

Career Highlights: Kasahara has contributed significantly to the field of biotechnology through his work with esteemed institutions such as the University of California and the National Institute of Transplantation Foundation. His dedication to innovation and research has led to the development of groundbreaking technologies that have the potential to transform healthcare practices worldwide.

Collaborations: Throughout his career, Kasahara has collaborated with talented individuals such as Christopher R Logg and James C Cicciarelli. Their combined expertise and ingenuity have resulted in the successful implementation of cutting-edge medical solutions that continue to impact the industry.

Conclusion: Noriyuki Kasahara's inventive spirit and commitment to advancing medical science have solidified his reputation as a pioneering figure in the field of biotechnology. Through his patented technologies and collaborative efforts, he has made significant contributions to improving patient care and outcomes, leaving a lasting legacy of innovation in the medical community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…